ProfileGDS4718 / 238245_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 59% 51% 65% 61% 53% 53% 71% 54% 62% 59% 49% 55% 57% 57% 59% 60% 52% 54% 50% 69% 60% 62% 57% 59% 54% 59% 54% 56% 53% 54% 55% 61% 59% 48% 59% 58% 60% 56% 56% 58% 56% 50% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9144257
GSM549102patient 115, normal, homogenized [OPG study]6.1027759
GSM549104patient 119, normal, homogenized [OPG study]5.5604851
GSM549108patient 138, normal, homogenized [OPG study]6.4720665
GSM549119patient 077, normal, homogenized [OPG study]6.1949661
GSM549133patient 032, cancer, homogenized [OPG study]5.618253
GSM549139patient 042, cancer, homogenized [OPG study]5.6821353
GSM549099patient 107, normal, homogenized [OPG study]6.8858471
GSM549109patient 139, normal, homogenized [OPG study]5.7660754
GSM549110patient 046, normal, homogenized [OPG study]6.231162
GSM549114patient 063, normal, homogenized [OPG study]6.0401159
GSM549122patient 082, normal, homogenized [OPG study]5.4555449
GSM549134patient 033, cancer, homogenized [OPG study]5.8013455
GSM549136patient 036, cancer, homogenized [OPG study]5.8662257
GSM549140patient 044, cancer, homogenized [OPG study]5.9224857
GSM549111patient 047, normal, homogenized [OPG study]6.0900659
GSM549113patient 057, normal, homogenized [OPG study]6.1339260
GSM549132patient 031, cancer, homogenized [OPG study]5.646852
GSM549137patient 038, cancer, homogenized [OPG study]5.7678554
GSM549142patient 047, cancer, homogenized [OPG study]5.6517650
GSM549100patient 110, normal, homogenized [OPG study]6.7538869
GSM549107patient 135, normal, homogenized [OPG study]6.093160
GSM549115patient 068, normal, homogenized [OPG study]6.2762962
GSM549116patient 072, normal, homogenized [OPG study]5.9080657
GSM549120patient 078, normal, homogenized [OPG study]6.0899359
GSM549131patient 030, cancer, homogenized [OPG study]5.6973754
GSM549118patient 074, normal, homogenized [OPG study]6.0512659
GSM549129patient 027, cancer, homogenized [OPG study]5.7430654
GSM549123patient 088, normal, homogenized [OPG study]5.8407456
GSM549124patient 006, cancer, homogenized [OPG study]5.7266153
GSM549126patient 015, cancer, homogenized [OPG study]5.7446954
GSM549128patient 025, cancer, homogenized [OPG study]5.7897355
GSM549103patient 117, normal, homogenized [OPG study]6.2114761
GSM549117patient 073, normal, homogenized [OPG study]5.9719959
GSM549138patient 041, cancer, homogenized [OPG study]5.394948
GSM549141patient 045, cancer, homogenized [OPG study]6.0496159
GSM549130patient 028, cancer, homogenized [OPG study]5.9839658
GSM549101patient 111, normal, homogenized [OPG study]6.1428360
GSM549105patient 128, normal, homogenized [OPG study]5.874556
GSM549106patient 134, normal, homogenized [OPG study]5.8417256
GSM549112patient 048, normal, homogenized [OPG study]5.9554858
GSM549125patient 011, cancer, homogenized [OPG study]5.8906156
GSM549127patient 024, cancer, homogenized [OPG study]5.5175250
GSM549135patient 035, cancer, homogenized [OPG study]5.628152